ESMO - Eur. Oncology· @myESMO · X·· 2 天前评分45
正文 · 原文
#ESMO26: Phase II data suggest selected patients with localised gastro-oesophageal adenocarcinoma (#GEA) may benefit from a dostarlimab watch-and-wait strategy that can achieve good responses without surgery
🔗 https://ow.ly/H76250ZZiMQ
#InsightsbyESMO #GICancers
847 浏览 · 3 赞 · 1 转发 · 0 回复
会议摘要
2877RO按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
https://esmocongress.esmo.org来源：ESMO - Eur. Oncology · x.com